181 related articles for article (PubMed ID: 6379121)
1. Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
Dillman RO; Shawler DL; Dillman JB; Royston I
J Clin Oncol; 1984 Aug; 2(8):881-91. PubMed ID: 6379121
[TBL] [Abstract][Full Text] [Related]
2. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.
Dillman RO; Beauregard J; Shawler DL; Halpern SE; Markman M; Ryan KP; Baird SM; Clutter M
J Biol Response Mod; 1986 Oct; 5(5):394-410. PubMed ID: 3490543
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy.
Shawler DL; Beauregard J; Halpern SE; Baird SM; Dillman RO
Clin Immunol Immunopathol; 1986 Oct; 41(1):43-54. PubMed ID: 3488861
[TBL] [Abstract][Full Text] [Related]
5. Human immune response to multiple injections of murine monoclonal IgG.
Shawler DL; Bartholomew RM; Smith LM; Dillman RO
J Immunol; 1985 Aug; 135(2):1530-5. PubMed ID: 3874237
[TBL] [Abstract][Full Text] [Related]
6. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
Schroff RW; Foon KA; Beatty SM; Oldham RK; Morgan AC
Cancer Res; 1985 Feb; 45(2):879-85. PubMed ID: 3871353
[TBL] [Abstract][Full Text] [Related]
7. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
8. Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.
Foon KA; Schroff RW; Bunn PA; Mayer D; Abrams PG; Fer M; Ochs J; Bottino GC; Sherwin SA; Carlo DJ
Blood; 1984 Nov; 64(5):1085-93. PubMed ID: 6333257
[TBL] [Abstract][Full Text] [Related]
9. T65 antigen modulation in a phase I monoclonal antibody trial with chronic lymphocytic leukemia patients.
Schroff RW; Farrell MM; Klein RA; Oldham RK; Foon KA
J Immunol; 1984 Sep; 133(3):1641-8. PubMed ID: 6379051
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.
Goldman-Leikin RE; Kaplan EH; Zimmer AM; Kazikiewicz J; Manzel LJ; Rosen ST
Exp Hematol; 1988 Nov; 16(10):861-4. PubMed ID: 3262528
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation.
Bertram JH; Gill PS; Levine AM; Boquiren D; Hoffman FM; Meyer P; Mitchell MS
Blood; 1986 Sep; 68(3):752-61. PubMed ID: 3488778
[TBL] [Abstract][Full Text] [Related]
12. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
[TBL] [Abstract][Full Text] [Related]
13. Immunologic differentiation of the Sézary syndrome due to cutaneous T-cell lymphoma and chronic actinic dermatitis.
Chu AC; Robinson D; Hawk JL; Meacham R; Spittle MF; Smith NP
J Invest Dermatol; 1986 Feb; 86(2):134-7. PubMed ID: 3528307
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody.
Carrasquillo JA; Bunn PA; Keenan AM; Reynolds JC; Schroff RW; Foon KA; Su MH; Gazdar AF; Mulshine JL; Oldham RK
N Engl J Med; 1986 Sep; 315(11):673-80. PubMed ID: 3489185
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic phenotyping of cutaneous lymphomas].
Kaudewitz P; Burg G; Smolle J; Braun-Falco O
Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
Foss FM; Raubitscheck A; Mulshine JL; Fleisher TA; Reynolds JC; Paik CH; Neumann RD; Boland C; Perentesis P; Brown MR; Frincke JM; Lollo CP; Larson SM; Carrasquillo JA
Clin Cancer Res; 1998 Nov; 4(11):2691-700. PubMed ID: 9829731
[TBL] [Abstract][Full Text] [Related]
17. Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody.
Miller RA; Levy R
Lancet; 1981 Aug; 2(8240):226-30. PubMed ID: 6114284
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy of lymphoid malignancy.
Lowder JN; Meeker TC; Levy R
Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318
[TBL] [Abstract][Full Text] [Related]
19. Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma.
Keenan AM; Weinstein JN; Carrasquillo JA; Bunn PA; Reynolds JC; Foon KA; Smarte NC; Ghosh B; Fejka RM; Larson SM
Cancer Res; 1987 Nov; 47(22):6093-9. PubMed ID: 3499222
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.
Rosen ST; Zimmer AM; Goldman-Leikin R; Gordon LI; Kazikiewicz JM; Kaplan EH; Variakojis D; Marder RJ; Dykewicz MS; Piergies A
J Clin Oncol; 1987 Apr; 5(4):562-73. PubMed ID: 3549989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
